South Africa’s Department of Health has expressed optimism regarding a new tuberculosis (TB) vaccine currently undergoing phase three trials. The vaccine’s development is being significantly supported by the Bill and Melinda Gates Foundation. If the trials demonstrate success, South Africa is actively preparing for potential access to the vaccine for its population. TB remains a major public health concern in the country, and a new vaccine could substantially impact disease rates. The department highlighted the importance of proactive preparation to ensure swift implementation should the vaccine prove effective. Positive trial results would represent a groundbreaking advancement in the fight against tuberculosis globally, offering renewed hope for controlling and potentially eradicating the disease.